Skip to main content
Premium Trial:

Request an Annual Quote

Miniaturized MS Shop Microsaic Sees H1 2011 Revenues Tumble 35 Percent

NEW YORK (GenomeWeb News) – Miniaturized mass spectrometry firm Microsaic Systems today announced that its revenues for the first half of 2011 fell 35 percent year over year, while losses increased 30 percent.

For the six months ended June 30, the Surrey, UK-based company posted receipts of £120,326 ($186,686), down from £185,761 a year ago. Its loss for the period rose to £852,264 from £656,619.

During the first half of the year, Microsaic's operational expenses climbed to £466,798 from £339,842, a 37 percent increase. It ended the first-half of 2011 with about £3.1 million in cash and cash equivalents.

The company, which began trading on the AIM market of the London Stock Exchange in April, raising £4 million, develops miniaturized chip-based mass spectrometers targeted for smaller laboratories as well as labs in need of additional instruments but short on space.

In addition to listing on AIM, company highlights for the first half of the year included initiation of commercial discussions with potential partners for OEM sales of Microsaic's 3500 MiD instrument, launched in January. The firm said it is now in negotiations with a total of five companies regarding possible OEM sales.

It added that since June 30, it has received the first order from an OEM partner.

Also, in August Microsaic hired Samantha Dunnage as sales and marketing manager to handle its direct marketing and sales of the 3500 MiD platform. Microsaic's strategy is to target niche, growth markets.

"We believe our innovative chip-based mass spectrometer technology is revolutionary and has the potential to address a large and growing market opportunity," Alan Finlay, CEO of Microsaic, said in a statement, adding the firm is "progressing commercial discussions as rapidly as possible."

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.